Close Menu

Biodesix

The study found that using Veristrat to guide patient therapy decreased the total lifetime direct medical cost per patient by $135.

The company cited as likely applications development of tests for guiding therapy in late-stage patients and support of drug development efforts.

The deal will leverage Inivata's technology platform and Biodesix's development and commercialization capabilities in the US.

The company plans to launch a PCR-based test for measuring three genes in the plasma of lung cancer patients and is also at work on an NGS-based panel.

Biodesix will use the investment to continue development of its blood-based molecular diagnostic technology platform and test menu.

NEW YORK (GenomeWeb) – The National Comprehensive Cancer Network has approved inclusion of Biodesix's VeriStrat proteomics test in its guidelines for non-small cell lung cancer, the Boulder, Colo.-based firm said today.

Agilent Technologies said this week that it has awarded its Agilent Thought Leader Award to Carlos Cordon-Cardo, a molecular pathologist at Mount Sinai Hospital

NEW YORK (GenomeWeb) – Biodesix said today that it has received a positive coverage decision from Highmark, a Blue Cross Blue Shield affiliate, for its Veristrat lung cancer test.

Drugmaker Aveo Oncology and test developer Biodesix entered into a partnership last week in which the two will share more equally the risks and profits of developing a personalized medicine product.

Proteomic diagnostics firm Biodesix and drug developer Aveo Oncology said this week that they are partnering to co-develop and commercialize Aveo's non-small cell lung cancer antibody drug ficlatuzumab and Biodesix's Veristrat as a companion test to predict best responders.

Pages

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.